Safety information updated on Canadian Humira label

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2005年 / 1038卷 / 1期

关键词：

Thrombocytopenia; Health Care Professional; Adalimumab; Pancytopenia; Anakinra;

D O I：

10.2165/00128415-200510380-00005

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[21] Positive opinion for Humira label extension in EU
不详
DRUG NEWS & PERSPECTIVES, 2004, 17 (04) : 242 - 242
[22] Alpha-interferons: safety information updated
Reactions Weekly, 2002, 894 (1) : 3 - 3
[23] Regularly updated drug product safety information on the Internet
Nightingale, SL
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17): : 1580 - 1580
[24] Ezetimibe labeling updated to include additional safety information
不详
FORMULARY, 2003, 38 (08) : 460 - 460
[25] Information letter on treatment of psoriasis with adalimumab (Humira®)
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2011, 138 (12): : 868 - 870
[26] Bextra label updated
Reactions Weekly, 2004, 1026 (1) : 2 - 2
[27] Relenza label updated
Reactions Weekly, 2008, 1197 (1) : 2 - 2
[28] JAK inhibitor safety information updated with risk minimisation measures
Reactions Weekly, 2023, 1951 (1) : 2 - 2
[29] Bevacizumab [Avastin] safety information has been updated in Canada
Reactions Weekly, 2011, 1378 (1) : 3 - 3
[30] Updated Crestor safety information: increased risks in Asian patients?
Reactions Weekly, 2005, 1042 (1) : 3 - 3

← 1 2 3 4 5 →